Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
eli lilly
4
×
genentech
4
×
life sciences
national blog main
national top stories
san francisco blog main
4
×
san francisco top stories
cancer
deals
indiana blog main
indiana top stories
investing
roche
agenus
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
celgene
clinical trials
detroit blog main
detroit top stories
fda
johnson & johnson
medullary thyroid cancer
national
new york blog main
new york top stories
non-small cell lung cancer
novartis
pain drug
pfizer
pralsetinib
raleigh-durham blog main
raleigh-durham top stories
What
drug
4
×
fda
approval
bio
blueprint
cancer
companies
latest
medicines
ret
roundup
address
alzheimer’s
approved
approves
candidate
carries
certain
currently
designed
different
digital
disease
epidemic
fail
fatty
frenzied
gene
genetic
growing
increases
known
led
liver
marketing
merck
muscle
nash
news
pact
Language
unset
Current search:
genentech
×
drug
×
" san francisco blog main "
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More